Fiche publication
Date publication
septembre 2025
Journal
Journal of Crohn's & colitis
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Allocca M, Jairath V, Sands BE, Rubin DT, Caron B, Laurent V, Novak K, Panaccione R, Bossuyt P, Bruining DH, Dignass A, Dotan I, Fletcher J, Fumery M, Furfaro F, Halfvarson J, Hart A, Kobayashi T, Krugliak Cleveland N, Kucharzik T, Laghi A, Lakatos PL, Leong RW, Loftus EV, Louis E, Magro F, Olivera PA, Sebastian S, Siegmund B, Vavricka SR, Wilson SR, Stoker J, Rimola J, Peyrin-Biroulet L, Danese S
Lien Pubmed
Résumé
Intestinal ultrasound (IUS) is increasingly used to monitor treatment efficacy in inflammatory bowel disease (IBD) trials. However, standardized definitions for response, remission, and optimal assessment timing remain undefined.An international expert consensus meeting was held to establish IUS endpoints for clinical trials.
Mots clés
endpoints, inflammatory bowel disease, intestinal ultrasound
Référence
J Crohns Colitis. 2025 09 18;:
